José Bismarck Ortiz Baptista

José Bismarck Ortiz Baptista

Auto-generated profile, based on publicly available information

José Bismarck Ortiz Baptista

Hospital Obrero Nro. 3, Caja Nacional de Salud. Santa Cruz Bolivia

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2003 in Academic Radiology
Verified
Journal Article
Closed access
SKShigeru Kiryu
Shigeru Kiryu
VRVassilios Raptopoulos
Vassilios Raptopoulos
JBJovanna Baptista
Jovanna Baptista
HHHiroto Hatabu
Hiroto Hatabu

1 February 2000 in Preventive Veterinary Medicine
Verified
Journal Article
Closed access
DSDaniel Scholl
Daniel Scholl
RTR.E Truax
R.E Truax
JBJ.M Baptista
J.M Baptista
KIK Ingawa
K Ingawa
KOK.A Orr
K.A Orr
BJB.F Jenny
B.F Jenny

14 April 2025 in Salud Integral y Comunitaria
Verified
Journal Article
Open access
PDF file
PGPaul Cardozo Gil
Paul Cardozo Gil
FPFernando Peralta
Fernando Peralta
Jhossmar Cristians Auza SantivañezJhossmar Cristians Auza Santivañez
Jhossmar Cristians Auza Santivañez
MVMariela Marpartida Vildoso
Mariela Marpartida Vildoso
EUEduardo Ustarez
Eduardo Ustarez
FBFreddy Ednildon Bautista-Vanegas
Freddy Ednildon Bautista-Vanegas
Introduction: immune thrombocytopenia (ITP) is an autoimmune disorder characterized by autoantibody-mediated destruction of platelets, resulting in low platelet count and increased risk of bleeding, and may be an initial manifestation of systemic lupus erythematosus (SLE), especially in patients with findings suggestive of autoimmunity.Clinical Case: a 52-year-old male presented with fever, hematuria, generalized petechiae (including mucous membranes), myalgia, mucosal bleeding, oliguria progressive to anuria, and severe arterial hypertension. Initial studies revealed severe anemia, severe thrombocytopenia, and acute kidney injury, which led to his admission to the Intensive Care Unit (ICU). Complementary studies showed positive ANA, low complement (C3, C4), and positive anti-Ro, while anti-dsDNA antibodies, ANCA, and markers of antiphospholipid syndrome were negative. Imaging revealed pulmonary edema with mild alveolar hemorrhage and renal ultrasound findings consistent with active lupus nephritis. These findings raised the possibility that severe thrombocytopenia was a prelude to SLE. After initial treatment refractory, the patient was escalated to rituximab, with a favorable response without complications, which allowed discharge from the ICU.Conclusions: this case highlights the importance of considering SLE in patients with refractory thrombocytopenia without apparent cause, even in men, and underlines the need for a multidisciplinary approach for timely diagnosis and treatment, thus preventing serious complications.

23 January 2025 in Salud Integral y Comunitaria
Verified
Journal Article
Open access
PDF file
PGPaul Cardozo Gil
Paul Cardozo Gil
FPFernando Peralta
Fernando Peralta
Jhossmar Cristians Auza SantivañezJhossmar Cristians Auza Santivañez
Jhossmar Cristians Auza Santivañez
MVMariela Marpartida Vildoso
Mariela Marpartida Vildoso
EUEduardo Ustarez
Eduardo Ustarez
FVFreddy Ednildon ¿Bautista Vanegas
Freddy Ednildon ¿Bautista Vanegas
Introduction: immune thrombocytopenia (ITP) is an autoimmune disorder characterized by autoantibody-mediated destruction of platelets, resulting in low platelet count and increased risk of bleeding, and may be an initial manifestation of systemic lupus erythematosus (SLE), especially in patients with findings suggestive of autoimmunity.Clinical Case: a 52-year-old male presented with fever, hematuria, generalized petechiae (including mucous membranes), myalgia, mucosal bleeding, oliguria progressive to anuria, and severe arterial hypertension. Initial studies revealed severe anemia, severe thrombocytopenia, and acute kidney injury, which led to his admission to the Intensive Care Unit (ICU). Complementary studies showed positive ANA, low complement (C3, C4), and positive anti-Ro, while anti-dsDNA antibodies, ANCA, and markers of antiphospholipid syndrome were negative. Imaging revealed pulmonary edema with mild alveolar hemorrhage and renal ultrasound findings consistent with active lupus nephritis. These findings raised the possibility that severe thrombocytopenia was a prelude to SLE. After initial treatment refractory, the patient was escalated to rituximab, with a favorable response without complications, which allowed discharge from the ICU.Conclusions: this case highlights the importance of considering SLE in patients with refractory thrombocytopenia without apparent cause, even in men, and underlines the need for a multidisciplinary approach for timely diagnosis and treatment, thus preventing serious complications.